![Thomas Nifong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Nifong
Corporate Officer/Principal bij Definiens AG
Profiel
Thomas Nifong is currently working as the Executive Vice President-Predictive Tests at Definiens AG.
Previously, he worked as the Vice President-Clinical Operations at Metamark Genetics, Inc. and as a Process Engineer at Unilever UK Ltd.
Dr. Nifong holds a doctorate degree from the University of Rochester and an undergraduate degree from Purdue University.
Actieve functies van Thomas Nifong
Bedrijven | Functie | Begin |
---|---|---|
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01-01-2014 |
Eerdere bekende functies van Thomas Nifong
Bedrijven | Functie | Einde |
---|---|---|
Unilever UK Ltd.
![]() Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Opleiding van Thomas Nifong
Purdue University | Undergraduate Degree |
Rochester Christian University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Unilever UK Ltd.
![]() Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Consumer Non-Durables |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |